AllClear
PricingSign in
FDADecember 30, 2024drug

Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.

What to do

FDA enforcement status: Ongoing

Brands named

rising pharma holdingrisingrising pharma

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →